Zachary Bogue

Cofounder and Managing Partner at DCVC

📍 San Francisco, California, United States🔄 Updated September 2026💼 19 investments📅 16 years investing🗓 Last invested Jul 2021𝕏 @upgrade_to_unlock
Operator-angel🌍 United States
19
Total investments
9
Early stage
5
Mid stage
0
Late stage
16y
Years active

Portfolio

16 investments · sorted by recency
All investments
Early stage
Mid stage
Late stage
Investor & Board Observer
Jul 2021
We are an end-to-end biotech developing transformational medicines, with technology at our core. Our ambition is to understand human biology in an unprecedented way; discovering therapies that will treat some of lifes most devastating diseases. We leverage single-cell and multi-omics measurements directly from patient tissue, functional assays and machine learning to drive disease understanding — from cause to cure. Medicines born from high-resolution biology, machine learning and clinical insights. Our Lab-in-the-Loop seamlessly integrates single-cell analysis, genomics and machine learning. We have developed powerful technologies which we apply to select druggable targets and develop transformational medicines.
Investor & Board member
Aug 2020
Our Mission: Urgently impact climate change, at scale, by harnessing the power of Asparagopsis seaweed to reduce methane from cows. This is because we believe: * Climate change is real. Humanity is running out of time to act. Agriculture/methane is a significant contributor to climate change. * Nature can inspire and technology can deliver a meaningful difference. Seaweed is an unrealized resource that nature has provided to reduce methane in cows. * We are realists about convincing the world to do things differently. We want to make change as easy as possible. * We are certain that we can make a difference by bringing individuals, communities, governments and industry together. The company’s bold vision is for Zero Methane Agriculture by bending the climate curve. because cutting methane will significantly slow short-term global warming. CH4’s urgent initiative is to cut methane emissions from livestock by making available to the world sustainable, globally-scaled products containing a unique seaweed. This special seaweed, Asparagopsis, has over 10 years of research behind it and has shown effects of 60-90% reduction in methane emissions from both dairy and beef cattle and sheep. As we, at CH4 Global, work to make Asparagopsis products real, we are committed to doing this in a way that makes it easy for farmers to adopt and that will benefit communities where we aqua-farm. We are collaborating with local communities to ensure that all can benefit from our work. Our Management Team and Advisory Board come with significant research, development, marketing, large-scale production, distribution and investment experience in major global companies. We are based in USA, New Zealand and Australia.
early stageFarming
Investor & Board member
Aug 2018
Oklos mission is to provide clean, reliable, affordable energy through the deployment of next-generation fast fission technology and recycling nuclear waste.
Investor
Aug 2018
C16 Biosciences uses innovative processes found in nature to brew sustainable alternatives to palm oil. Palm oil is everywhere: it’s in our food, clothes, shampoo, and even the fuel that powers our cars. But this $61 billion industry has drastic environmental and societal costs: rainforests from Costa Rica to Indonesia are destroyed to make way for oil palm tree plantations, releasing carbon dioxide into the atmosphere and destroying habitats for people and endangered wildlife along the way. But palm oil doesn't have to be a problem. There remains an urgent need for consumers and companies alike to switch to environmentally conscious, sustainable palm oil products. C16 was founded with the objective of creating a sustainable, environmentally friendly alternative to conflict palm oil. By offering producers, refiners, traders and consumers of palm oil an opportunity to invest part of their production into bio-based oils and sustainability efforts, our aim is to reduce the environmental footprint of palm oil production and protect precious natural land, wildlife, and resources in the process. We've developed technology to brew a sustainable alternative to palm oil from microbes. Fermentation is a well-proven commercial process that has been used for centuries to convert raw materials into consumable commercial products consumed by billions of people every day. We believe that brewing palm oil like beer is the best and most likely path to developing a truly sustainable palm oil alternative. Our palm oil is sustainable -- it doesn't involve deforestation, endangering precious animal species, or forcing inhumane labor practices. The result is a world where consumers can enjoy the products they love without worrying about the dangerous practices involved in making them.
Investor & Board member
Apr 2018
Twelve™ produces fuels and feedstock for thousands of everyday products from CO2 and electricity. This is eManufacturing—advanced industrial technologies that change the way we make things from the molecule up. A world made from air™
Investor & Board member
Sep 2016
Founded in 2014, Insight M is a consultative methane emissions management company driven by our unwavering commitment to scientific rigor and overall customer success. We are the energy industry’s leader in high-frequency aerial methane detection. Our team is comprised of leading methane scientists, engineers, and strategists whose sole focus is to create evidence-based solutions that empower our customers to achieve operational excellence in methane management. We help oil and gas operators to take a pragmatic approach to reducing their emissions—helping them keep gas in the pipe and protect their brand from public and regulatory scrutiny. 
 Our work has saved our oil and gas customers over $500 million in gas value and mitigated over 140 billion cubic feet of methane from entering the atmosphere—equivalent to taking 54 million gas cars off the road for a year.
early stageOil and Gas
Investor & Board member
Aug 2016
Recursion (NASDAQ: RXRX) is a clinical stage TechBio company leading the space by decoding biology to radically improve lives. Enabling its mission is the Recursion OS, a platform built across diverse technologies that continuously generate one of the world’s largest proprietary biological and chemical datasets. Recursion leverages sophisticated machine-learning and AI algorithms to distill from its dataset a collection of trillions of searchable relationships across biology and chemistry unconstrained by human bias. By commanding massive experimental scale — up to millions of wet lab experiments weekly — and massive computational scale — owning and operating one of the most powerful supercomputers in the world, Recursion is uniting technology, biology and chemistry to advance the future of medicine. Recursion is headquartered in Salt Lake City, where it is a founding member of BioHive, the Utah life sciences industry collective. Recursion also has offices in Montréal, New York, London, and the Oxford area. Learn more at www.Recursion.com, or connect on X (formerly Twitter) and LinkedIn.
Angel Investor
May 2016
Boom Supersonic is redefining commercial flight by bringing supersonic flight back to the skies with Overture. This historic commercial airliner is designed and committed to industry-leading standards of speed, safety, and sustainability. Boom’s vision is to bring families, businesses, and cultures closer together through supersonic travel and make the world dramatically more accessible. Founded in 2014, Boom has assembled a team of over 150 full-time employees who have made contributions to over 220 air and spacecraft programs. For more information, please visit https://boomsupersonic.com.
Investor & Board Observer
Oct 2015
Freenome is a high-growth biotech company on a mission since 2014 to create tools that empower everyone to prevent, detect, and treat their disease. To achieve this mission, Freenome is developing next-generation blood tests to detect cancer in its earliest, most treatable stages using our multiomics platform and machine learning techniques. Our first blood test will detect early-stage colorectal cancer and advanced adenomas. We have raised more than $1.1 billion from leading investors like Perceptive Advisors, RA Capital Management, Roche Venture Fund, Kaiser Permanente, Novartis and the American Cancer Society’s BrightEdge Ventures. A ‘Freenomer’ is a mission-driven employee who is fueled by the opportunity to make a positive impact on patients lives, who thrives in a culture of respect and cross collaboration, and whose work makes a significant impact on the company and their career.
Investor, Board Observer and Board member
May 2015
Tala is the first financial platform for the Global Majority. Our leading money app bridges digital and cash ecosystems to deliver instant access to credit, payments, savings, and transfer services to millions of customers on three continents. Powered by advanced technology and human creativity, Tala is reinventing financial infrastructure to solve what legacy institutions can’t or won’t, in order to unlock global economic progress. Tala has raised nearly half a billion dollars in investments and debt, backed by leading venture and impact investors including Upstart, the Stellar Development Foundation, RPS Ventures, the J. Safra Group, IVP, Revolution Growth, Lowercase Capital, and PayPal Ventures. Tala has been named to Fortune’s Impact 20, CNBC’s Disruptor 50 list four years in a row, and Forbes’ Fintech 50 list for eight consecutive years. Tala’s impact has been highlighted by the New York Times, NPR, Forbes, the Financial Times, the Wall Street Journal and TED, among others. Tala is headquartered in Santa Monica with offices in Nairobi, Manila, Mexico City, and Bangalore.
Investor & Board Observer
Sep 2014
Pivot Bio is one of the worlds leading innovative agtech companies, delivering farmers patented crop nutrition technologies.
Investor & Board member
Mar 2013
Planet is the leading provider of global, daily satellite imagery and insights. Planet is driven by a mission to image all of Earth’s landmass every day, and make global change visible, accessible, and actionable. Founded in 2010 by three NASA scientists, Planet designs, builds, and operates the largest fleet of imaging satellites, as well as online software, tools and analytics needed to deliver data to users. Decision makers in business, government, and within organizations use Planets data and machine learning-powered analytics to develop new technologies, drive revenue, power research, and make informed, timely decisions to solve our worlds toughest challenges. Visit us at https://www.planet.com/
Investor
2012
Cask makes building and running big data solutions on-premises, in the cloud or in hybrid environments easy with Cask Data Application Platform (CDAP), the first unified integration platform for big data. CDAP reduces the time from prep to production for data lakes and data applications by 80%, empowering the business to make better decisions faster. CDAP is open source and accelerates time to value from Hadoop and Spark through standardized APIs, configurable templates and visual interfaces. With a radically simplified developer experience and a code-free self-service environment, CDAP enables enterprise IT to broaden the big data user base and seamlessly integrates with existing MDM, BI and security and governance solutions. As a standardization layer on top of big data platforms such as EMR, HDInsight, GCS, Cloudera, Hortonworks and MapR, CDAP provides the following essential capabilities: -Abstraction of data in a Hadoop/Spark environment through logical representations of underlying data; -Integration of components of the big data ecosystem into a single platform; -Portability of data lakes and data applications through decoupling underlying infrastructures; -APIs, services and self-service tools that enable faster application development and deployment; and -Higher degrees of operational control in production through enterprise best practices. Based in Palo Alto, CA, the company is backed by leading investors including Safeguard Scientifics, Battery Ventures, Ignition Partners and Andreessen Horowitz. Cask customers and partners include AT&T, AWS, Cloudera, Ericsson, Google, Hortonworks, IBM, MapR, Microsoft, Salesforce, Tableau, Thomson Reuters, and others. For more information, visit the Cask website at cask.co and follow @caskdata.
Investor
Mar 2011
A fast growing innovator of cloud-based acceleration technologies, Cotendo offers an integrated suite of Web and Mobile Acceleration Services from its global distributed point of presence (POPs). Cotendos single platform software was built from the ground-up and includes acceleration services for dynamic web applications, static and dynamic web content, SSL, Advanced DNS, Adaptive Image Compression, performance monitoring and automatic failover as well as real-time reports and analytics. Cotendo also offers a distributed cloud application environment called Cloudlet™ that allows decision-making (logic, data) at the edge, closest to the end users. Cotendos customer base includes Fortune 500 enterprises, Tier 1 telecommunications providers and the worlds largest social networks, eCommerce sites, and advertising networks. The companys management team is comprised of acknowledged innovators in intelligent content management, content delivery networks, and mobile performance and has been honored with awards including the Red Herring Top 100, AlwaysOn Global 250 Private Companies, the MIT TR Top 50 Most Innovative companies, and the Businessweek Top 50 tech start-ups. Founded in 2008, Cotendo is funded by Sequoia Capital, Benchmark Capital and Tenaya Capital. The company is headquartered in Silicon Valley with R&D based in Israel. For more information about Cotendo and its Web and Mobile Acceleration Services Suite, visit http://www.cotendo.com
Investor & Advisor
Apr 2010
For new Metamarkets-related business inquiries, please visit RillData.com. Rill's team recently acquired & rebuilt the Metamarkets tech stack from Snap, and are now powering self-serve, partner-facing dashboards at dozens of media tech firms, including Comcast/Freewheel, Ericsson, Liftoff, AT&T, and more.
Show all 16 investments ↓
Experience · 24 entries
All (24)
Investments (19)
Founder (2)
Board (10)
2021
Investor & Board Observer
Jul 2021
We are an end-to-end biotech developing transformational medicines, with technology at our core. Our ambition is to understand human biology in an unprecedented way; discovering therapies that will treat some of lifes most devastating diseases. We leverage single-cell and multi-omics measurements directly from patient tissue, functional assays and machine learning to drive disease understanding — from cause to cure. Medicines born from high-resolution biology, machine learning and clinical insights. Our Lab-in-the-Loop seamlessly integrates single-cell analysis, genomics and machine learning. We have developed powerful technologies which we apply to select druggable targets and develop transformational medicines.
2020
Investor & Board member
Aug 2020
Our Mission: Urgently impact climate change, at scale, by harnessing the power of Asparagopsis seaweed to reduce methane from cows. This is because we believe: * Climate change is real. Humanity is running out of time to act. Agriculture/methane is a significant contributor to climate change. * Nature can inspire and technology can deliver a meaningful difference. Seaweed is an unrealized resource that nature has provided to reduce methane in cows. * We are realists about convincing the world to do things differently. We want to make change as easy as possible. * We are certain that we can make a difference by bringing individuals, communities, governments and industry together. The company’s bold vision is for Zero Methane Agriculture by bending the climate curve. because cutting methane will significantly slow short-term global warming. CH4’s urgent initiative is to cut methane emissions from livestock by making available to the world sustainable, globally-scaled products containing a unique seaweed. This special seaweed, Asparagopsis, has over 10 years of research behind it and has shown effects of 60-90% reduction in methane emissions from both dairy and beef cattle and sheep. As we, at CH4 Global, work to make Asparagopsis products real, we are committed to doing this in a way that makes it easy for farmers to adopt and that will benefit communities where we aqua-farm. We are collaborating with local communities to ensure that all can benefit from our work. Our Management Team and Advisory Board come with significant research, development, marketing, large-scale production, distribution and investment experience in major global companies. We are based in USA, New Zealand and Australia.
early stageFarming
2018
Investor & Board member
Aug 2018
Oklos mission is to provide clean, reliable, affordable energy through the deployment of next-generation fast fission technology and recycling nuclear waste.
Investor
Aug 2018
C16 Biosciences uses innovative processes found in nature to brew sustainable alternatives to palm oil. Palm oil is everywhere: it’s in our food, clothes, shampoo, and even the fuel that powers our cars. But this $61 billion industry has drastic environmental and societal costs: rainforests from Costa Rica to Indonesia are destroyed to make way for oil palm tree plantations, releasing carbon dioxide into the atmosphere and destroying habitats for people and endangered wildlife along the way. But palm oil doesn't have to be a problem. There remains an urgent need for consumers and companies alike to switch to environmentally conscious, sustainable palm oil products. C16 was founded with the objective of creating a sustainable, environmentally friendly alternative to conflict palm oil. By offering producers, refiners, traders and consumers of palm oil an opportunity to invest part of their production into bio-based oils and sustainability efforts, our aim is to reduce the environmental footprint of palm oil production and protect precious natural land, wildlife, and resources in the process. We've developed technology to brew a sustainable alternative to palm oil from microbes. Fermentation is a well-proven commercial process that has been used for centuries to convert raw materials into consumable commercial products consumed by billions of people every day. We believe that brewing palm oil like beer is the best and most likely path to developing a truly sustainable palm oil alternative. Our palm oil is sustainable -- it doesn't involve deforestation, endangering precious animal species, or forcing inhumane labor practices. The result is a world where consumers can enjoy the products they love without worrying about the dangerous practices involved in making them.
Investor & Board member
Apr 2018
Twelve™ produces fuels and feedstock for thousands of everyday products from CO2 and electricity. This is eManufacturing—advanced industrial technologies that change the way we make things from the molecule up. A world made from air™
Show all 24 entries ↓
Investment activity
2010–2021 · 19 investments
20102201132012220131201412015220163201832020120211
Recent (last 2 years)Earlier